Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines.

MLA

Dong, Chunhong, et al. “Enhancing Cross-Protection against Influenza by Heterologous Sequential Immunization with MRNA LNP and Protein Nanoparticle Vaccines.” Nature Communications, vol. 15, no. 1, July 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41467-024-50087-5.

APA

Dong, C., Zhu, W., Wei, L., Kim, J. K., Ma, Y., Kang, S.-M., & Wang, B.-Z. (2024). Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nature Communications, 15(1), 1–14. https://doi.org/10.1038/s41467-024-50087-5

Chicago

Dong, Chunhong, Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma, Sang-Moo Kang, and Bao-Zhong Wang. 2024. “Enhancing Cross-Protection against Influenza by Heterologous Sequential Immunization with MRNA LNP and Protein Nanoparticle Vaccines.” Nature Communications 15 (1): 1–14. doi:10.1038/s41467-024-50087-5.